Hormone therapy is known as one of the most effective means of treating menopausal symptoms like decreasing the risk of bone fractures, hot flashes, and diabetes. However, it has always been a factor responsible for stroke, blood clots, and certain forms of cancer. A recent study revealed that the effect of such therapies on the mortality rate over 18 years is neutral. It is reassuring news for women considering getting hormone therapy.
Researchers have studied the long-term rates of death due to hormone therapy trials. This study was conducted on postmenopausal women. During the study, women were tested with the most common forms of menopausal hormone therapy that is a combination of estrogen and progestin. It helped ProspectMedical in assessing the risks and benefits of the treatment.
No effect on woman mortality
Upon comprehensive research, the experts found that the overall mortality or death from vascular disease, chronic illness, or cancer in women aged 52-79 has decreased significantly. Women who received hormone therapy have a 30% lower threat than others. Over several years of cumulative follow-up differences in each group is no longer significant.
These findings proved the clinical guidelines for the use of hormone therapy on menopausal women. It is highly effective in eliminating the symptoms of hot flashes and other related conditions. However, physicians never recommend the widespread use of hormone therapy for the prevention of cardiovascular diseases. In clinical decision making consideration should always be made based on the risks and benefits of an individual patient. If you need comprehensive medical guidance on hormone therapy then visit sch-culvercity.com. Prospect medical holdings have an extensive network of primary and specialty care physicians for treating patients. They are backed by a team of trained professionals who guide every patient in finding a suitable treatment plan as per their needs and budget.
